Preoperative Studies for ESRD Patient on RRT Undergoing Retinal Surgery
For a patient with ESRD on renal replacement therapy, hypertension, and CAD scheduled for retinal surgery, obtain the following preoperative studies: complete blood count, comprehensive metabolic panel (including electrolytes, BUN, creatinine), coagulation profile (PT/INR, platelet count), ECG, and cardiac troponin levels. 1, 2
Essential Laboratory Studies
Hematologic and Metabolic Assessment
- Complete blood count to evaluate for anemia (common in ESRD due to decreased erythropoietin) and thrombocytopenia, both of which increase surgical bleeding risk 1, 2
- Serum electrolytes with particular attention to potassium levels, as hyperkalemia poses significant perioperative cardiac risk in dialysis patients 1, 2
- Blood urea nitrogen and creatinine to assess current renal function status 1
- Calcium, magnesium, phosphate, and bicarbonate levels to evaluate metabolic bone disease and acid-base status 1
Coagulation Assessment
- Bleeding time measurement is critical, as values >10-15 minutes indicate high hemorrhage risk in ESRD patients due to platelet dysfunction 1
- Prothrombin time and platelet count should be checked preoperatively in all intermediate- and high-risk patients 1
- If platelet count is <50,000/mm³, platelet transfusion should be considered 1
Cardiovascular Evaluation
Cardiac Risk Assessment
- 12-lead ECG is indicated for all intermediate- and high-risk patients undergoing surgery 1
- Cardiac troponin levels should be measured preoperatively and at 24 and 48 hours postoperatively in intermediate- and high-risk patients, as this population has elevated cardiovascular mortality 1
- Given the patient's CAD, a preoperative risk assessment for ischemic heart disease should be performed 1
Blood Pressure Monitoring
- Vital signs including blood pressure and heart rate should be checked within 2 hours preoperatively 1
- Blood pressure should be well-controlled (consistently <180/110 mm Hg) before proceeding with surgery 1, 3
Dialysis-Specific Considerations
Timing and Access Evaluation
- Dialysis should be performed the day before surgery to optimize fluid and electrolyte balance 2
- Examine the dialysis access (arteriovenous fistula or graft) for signs of infection and assess patency 2
- Additional dialysis sessions prior to surgery do not improve outcomes and are not recommended 2
Functional Status Assessment
- Functional capacity evaluation using the two-flight of stairs test or Duke Activity Status Index (DASI) should be performed preoperatively 1
Critical Pitfalls to Avoid
Medication Management
- Discontinue ACE inhibitors and ARBs 24 hours before surgery to reduce risk of severe intraoperative hypotension and hemodynamic instability 3, 2
- Hold diuretics on the day of surgery to prevent volume depletion and electrolyte disturbances 3
- Continue beta-blockers perioperatively if the patient is already taking them chronically to prevent rebound hypertension 1
- Never start beta-blockers on the day of surgery in beta-blocker-naïve patients, as this is potentially harmful 1
Electrolyte Correction
- Correct hypokalemia and hypomagnesemia before surgery to reduce risk of perioperative arrhythmias, as hypokalemia occurs in up to 34% of surgical patients and increases ventricular arrhythmia risk 3
Glycemic Control
- For diabetic ESRD patients, ensure adequate glycemic control preoperatively, as this population has particularly high perioperative risk 2, 4
Additional Considerations
Antibiotic Prophylaxis Planning
- Review antibiotic allergy history, as prophylactic antibiotics will be needed with dose adjustments based on renal function 1
- For penicillin-allergic patients, alternative regimens must be planned in advance 1